← Back to headlines
Medical Hedge Fund Sells Shares of Enliven Therapeutics
A medical hedge fund has sold 281,000 shares of Enliven Therapeutics (ELVN), prompting questions about the stock's future.
24 Jun, 19:32 — 24 Jun, 19:32
Sources
Showing 1 of 1 sources
